Skip to main content
. Author manuscript; available in PMC: 2013 Oct 25.
Published in final edited form as: J Clin Oncol. 2008 Jun 1;26(16):10.1200/JCO.2007.14.8114. doi: 10.1200/JCO.2007.14.8114

Table 4.

Typology of Video Recorded Patient-Physician Interactions

Type of Visit* No. %
Clinical trial never mentioned 100 43
Clinical trial mentioned, physician rejects trial option 27 11
Clinical trial mentioned, patient rejects trial option 0 00
Clinical trial discussed, no offer made 44 19
Clinical trial discussed, explicit offer made (where patient can respond either “yes” or “no” to the opportunity) 47 20
Other 8 03
Video/audio recording problems (not useable) 9 04
Total 235 100

NOTE. Sample size includes both study sites. Refusal rates were unavailable for the first cancer center. At the second cancer center, 151 patients and their family/ companions were invited to participate in the project, and 108 (72%) agreed.

*

There were no instances in which a physician mentioned a clinical trial (or began to discuss it) and the patient rejected the option outright. Of visits observed, 84% were first visits; 72% of visits where clinical trials were explicitly offered were first visits. Ninety-four percent of the patients were in interactions where trials were offered; 77% of patients in interactions where trials were not explicitly offered knew they had a cancer diagnosis, and treatment options were discussed.

The majority of patients were diagnosed with respiratory cancers (42%), followed by digestive (22%), leukemia/myeloma/lymphoma (14%); breast (5%); male genital (5%); other (5%); and not cancer/unconfirmed (7%; classified by Surveillance, Epidemiology, and End Results categories). Patients receiving a trial offer were diagnosed as follows: respiratory cancers (23%); digestive (30%); leukemia/myeloma/lymphoma (11%); breast (8%); other (17%); and no cancer/not confirmed (0%).